Table 2.

Univariable and multivariable comparisons of patients with or without orthostatic hypotension.

Variables	OH (n = 110) n (%)	No OH (n = 61) n (%)	Univariable analysis		Multivariable analysis
			Risk ratio (95% CI)	p-value	Risk ratio (95% CI)	p-value
≥ 0.5% weight loss/day	34 (31)	9 (15)	2.6 (1.2, 5.9)	0.022	2.7 (1.1, 7)	0.038
Antihistamine	5 (5)	13 (21)	0.2 (0.06, 0.5)	0.002	0.2 (0.06, 0.8)	0.017
Antihypertensives	57 (52)	22 (36)	2 (1, 3.8)	0.038	3.1 (1.3, 7.4)	0.012
Gabapentin	37 (32.5)	8 (13)	3.3 (1.4, 7.6)	0.006	4.5 (1.5, 13.2)	0.006
Proton pump inhibitor	40 (36)	38 (62)	0.4 (0.2, 0.7)	0.002	0.3 (0.1, 0.7)	0.003
White race	103 (94)	50 (83)	3.4 (1.2, 10)	0.023	5.9 (1.3, 26.5)	0.02
≥ CR	24 (22)	22 (36)	0.5 (0.2, 1)	0.046	0.6 (0.3, 1.4)	0.23
Age at BMT	59 (median)	59.5 (median)	1 (1, 1)	0.9	1 (0.9, 1)	0.35
Female	58 (53)	29 (48)	1.2 (0.7, 2.3)	0.52	0.9 (0.4, 2)	0.8
LVEF ≥ 55%	107 (97)	54 (89)	4.6 (1.2, 18.6)	0.031	2.5 (0.4, 13.6)	0.3

The table outlines variables associated with increased or decreased risk of developing OH.

Bolded p-value indicate variables significant in multivariable analysis.